Suchergebnisse - "Hingle, Martin"

PubPharm (9)

1

The importance of dissolution for orally inhaled drug products : pharmaceutical, regulatory, and clinical considerations

enthalten in: Expert opinion on drug delivery | 2023

von Somby, K. | Hingle, M. | Tomic, I. | +1

2

An IQ Consortium Perspective on Connecting Dissolution Methods to In Vivo Performance : Analysis of an Industrial Database and Case Studies to Propose a Workflow

enthalten in: The AAPS journal | 2022

von Aburub, A. | Chen, Y. | Chung, J. | +10

3

An IQ Consortium Perspective on Connecting Dissolution Methods to In Vivo Performance: Analysis of an Industrial Database and Case Studies to Propose a Workflow

enthalten in: The AAPS journal | 2022

von Aburub, A. | Chen, Y. | Chung, J. | +10

4

An IQ Consortium Perspective on Connecting Dissolution Methods to In Vivo Performance: Analysis of an Industrial Database and Case Studies to Propose a Workflow

enthalten in: AAPS PharmSci | 2022

von Aburub, A. | Chen, Y. | Chung, J. | +10

5

Negative Food Effect of Danirixin : Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK

enthalten in: Pharmaceutical research | 2020

von Lloyd, R. | Hingle, M. | Bloomer, J. | +9

6

Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK

enthalten in: Pharmaceutical research | 2020

von Lloyd, R. | Hingle, M. | Bloomer, J. | +9

7

Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK

enthalten in: Pharmaceutical research | 2020

von Lloyd, R. | Hingle, M. | Bloomer, J. | +9

8

Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK

enthalten in: Pharmaceutical research | 2020

von Lloyd, R. | Hingle, M. | Bloomer, J. | +9

9

Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase δ Inhibitor

enthalten in: The Journal of pharmacology and experimental therapeutics | 2019

von Begg, M. | Edwards, C. | Hamblin, J. | +16

1
[1]